The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Gold MC, Cerri S, Smyk-Pearson S, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010;8(6):e1000407. doi:10.1371/journal.pbio.1000407
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Martin E, Peguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010;11(8):701–708. doi:10.1038/ni.1890
   PubMed Web of Science ®Google Scholar
• Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood. 2011;117(4):1250–1259. doi:10.1182/blood-2010-08-303339
   PubMed Web of Science ®Google Scholar
• Tilloy F, Treiner E, Park SH, et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med. 1999;189(12):1907–1921. doi:10.1084/jem.189.12.1907
   PubMed Web of Science ®Google Scholar
• Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164–169. doi:10.1038/nature01433
   PubMed Web of Science ®Google Scholar
• Reantragoon R, Corbett AJ, Sakala IG, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med. 2013;210(11):2305–2320. doi:10.1084/jem.20130958
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Koay HF, McCluskey J, et al. The biology and functional importance of MAIT cells. Nat Immunol. 2019;20(9):1110–1128. doi:10.1038/s41590-019-0444-8
   PubMed Web of Science ®Google Scholar
• Trivedi S, Labuz D, Anderson CP, et al. Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis. Elife. 2020;9. doi:10.7554/eLife.55615
   Web of Science ®Google Scholar
• Ling L, Lin Y, Zheng W, et al. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients. Sci Rep. 2016;6:20358. doi:10.1038/srep20358
   PubMed Web of Science ®Google Scholar
• Zabijak L, Attencourt C, Guignant C, et al. Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients. Cancer Immunol Immunother. 2015;64(12):1601–1608. doi:10.1007/s00262-015-1764-7
   PubMed Web of Science ®Google Scholar
• Rodin W, Sundstrom P, Ahlmanner F, et al. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients. Cancer Immunol Immunother. 2021. doi:10.1007/s00262-021-02939-y.
   PubMed Web of Science ®Google Scholar
• Rouxel O, Da SJ, Beaudoin L, et al. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol. 2017;18(12):1321–1331.
   PubMed Web of Science ®Google Scholar
• Rahimpour A, Koay HF, Enders A, et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med. 2015;212(7):1095–1108. doi:10.1084/jem.20142110
   PubMed Web of Science ®Google Scholar
• Sundstrom P, Ahlmanner F, Akeus P, et al. Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-gamma. J Immunol. 2015;195(7):3472–3481. doi:10.4049/jimmunol.1500258
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhu M, Marley JL, et al. The combined action of monocytic myeloid-derived suppressor cells and mucosal-associated invariant T cells promotes the progression of cervical cancer. Int J Cancer. 2021;148(6):1499–1507. doi:10.1002/ijc.33411
   PubMed Web of Science ®Google Scholar
• Fergusson JR, Fleming VM, Klenerman P. CD161-expressing human T cells. Front Immunol. 2011;2:36. doi:10.3389/fimmu.2011.00036
   PubMed Web of Science ®Google Scholar
• Mathewson ND, Ashenberg O, Tirosh I, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184(5):1281–1298. doi:10.1016/j.cell.2021.01.022
   PubMed Web of Science ®Google Scholar
• Ebert P, Cheung J, Yang Y, et al. MAP kinase inhibition promotes T cell and anti-tumor activity in combination with PD-L1 checkpoint blockade. Immunity. 2016;44(3):609–621. doi:10.1016/j.immuni.2016.01.024
   PubMed Web of Science ®Google Scholar
• Borst J, Busselaar J, Bosma D, et al. Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy. Eur J Immunol. 2021;51(8):1911–1920. doi:10.1002/eji.202048994
   PubMed Web of Science ®Google Scholar
• Andrews LP, Yano H, Vignali D. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups. Nat Immunol. 2019;20(11):1425–1434. doi:10.1038/s41590-019-0512-0
   PubMed Web of Science ®Google Scholar
• De Biasi S, Gibellini L, Lo TD, et al. Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy. Nat Commun. 2021;12(1):1669. doi:10.1038/s41467-021-21928-4
   PubMed Web of Science ®Google Scholar
• Ju JK, Cho YN, Park KJ, et al. Activation, deficiency, and reduced IFN-gamma production of mucosal-associated invariant T cells in patients with inflammatory bowel disease. J Innate Immun. 2020;12(5):422–434. doi:10.1159/000507931
   PubMed Web of Science ®Google Scholar
• Shao C, Zhu C, Zhu Y, et al. Decrease of peripheral blood mucosal-associated invariant T cells and impaired serum Granzyme-B production in patients with gastric cancer. Cell Biosci. 2021;11(1):12. doi:10.1186/s13578-020-00518-9
   PubMed Web of Science ®Google Scholar
• Shaler CR, Tun-Abraham ME, Skaro AI, et al. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment. Cancer Immunol Immunother. 2017;66(12):1563–1575. doi:10.1007/s00262-017-2050-7
   PubMed Web of Science ®Google Scholar